• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子在食管鳞癌放射抗拒中的作用。

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.

机构信息

Department of Radiation Oncology, Huai'an Hospital Affiliated to Xuzhou Medical University, Huai'an City, Jiangsu Province, China.

Department of Radiation Oncology, The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.

出版信息

J Cancer Res Clin Oncol. 2023 Jun;149(6):2543-2550. doi: 10.1007/s00432-022-04122-x. Epub 2022 Jun 29.

DOI:10.1007/s00432-022-04122-x
PMID:35767192
Abstract

Vascular endothelial growth factor (VEGF) is related to the radiation resistance of tumors, resulting in the failure of tumor radiotherapy. The purpose of this study was to discuss the role of VEGF in radiotherapy resistance of esophageal squamous cell carcinoma (ESCC). We used the VEGF kit by ELISA to detect the serum VEGF level of ESCC patients who only received radiotherapy. The expression of VEGF in ESCC cells after siRNA treatment was verified by Western blot. The sensitivity of ESCC cells to radiation after knocking down VEGF was analyzed by Clonogenic assay and Cell counting kit (CCK-8). The results showed that the level of serum VEGF in patients with ESCC before and after radiotherapy was related to the clinical response, and it was confirmed that knocking down the expression of VEGF in ESCC cells improved the sensitivity to radiation.

摘要

血管内皮生长因子(VEGF)与肿瘤的辐射抗性有关,导致肿瘤放疗失败。本研究旨在探讨 VEGF 在食管鳞癌(ESCC)放疗抵抗中的作用。我们使用 ELISA 试剂盒检测仅接受放疗的 ESCC 患者的血清 VEGF 水平。通过 Western blot 验证 ESCC 细胞经 siRNA 处理后 VEGF 的表达。通过集落形成实验和 CCK-8 分析敲低 VEGF 后 ESCC 细胞对辐射的敏感性。结果表明,放疗前后 ESCC 患者血清 VEGF 水平与临床反应相关,证实敲低 ESCC 细胞中 VEGF 的表达可提高其对辐射的敏感性。

相似文献

1
Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.血管内皮生长因子在食管鳞癌放射抗拒中的作用。
J Cancer Res Clin Oncol. 2023 Jun;149(6):2543-2550. doi: 10.1007/s00432-022-04122-x. Epub 2022 Jun 29.
2
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.血管内皮生长因子 C 敲低对食管鳞癌的影响。
J Cancer Res Clin Oncol. 2012 Jan;138(1):133-9. doi: 10.1007/s00432-011-1079-9. Epub 2011 Nov 6.
3
Expression of nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues.核干细胞因子、表皮生长因子及其受体在人食管鳞状细胞癌组织中的表达。
J Cancer Res Clin Oncol. 2010 Apr;136(4):587-94. doi: 10.1007/s00432-009-0693-2. Epub 2009 Oct 13.
4
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.Ets-1和血管内皮生长因子(VEGF)的表达与食管鳞状细胞癌的肿瘤血管生成、淋巴结转移及患者生存率相关。
J Cancer Res Clin Oncol. 2003 Jul;129(7):430-6. doi: 10.1007/s00432-003-0457-3. Epub 2003 Jul 8.
5
YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma.YAP 抑制剂维替泊芬抑制食管鳞癌细胞血管生成并克服化疗耐药性。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7703-7716. doi: 10.1007/s00432-023-04722-1. Epub 2023 Mar 31.
6
EZH2 suppresses IR-induced ferroptosis by forming a co-repressor complex with HIF-1α to inhibit ACSL4: Targeting EZH2 enhances radiosensitivity in KDM6A-deficient esophageal squamous carcinoma.EZH2通过与HIF-1α形成共抑制复合物来抑制铁死亡诱导因子(IR)诱导的铁死亡,从而抑制ACSL4:靶向EZH2可增强KDM6A缺陷型食管鳞状细胞癌的放射敏感性。
Cell Death Differ. 2025 Feb 7. doi: 10.1038/s41418-025-01451-5.
7
Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.Gli1作为食管癌干细胞的潜在调节因子,被确定为食管鳞状细胞癌的独立不良预后因素。
J Cancer Res Clin Oncol. 2017 Feb;143(2):243-254. doi: 10.1007/s00432-016-2273-6. Epub 2016 Sep 28.
8
Low TIF1γ Expression is Associated with Cancer Aggressiveness and Shorter Recurrence-Free Survival in Patients with Esophageal Squamous Cell Carcinoma.低TIF1γ表达与食管鳞状细胞癌患者的肿瘤侵袭性及较短的无复发生存期相关。
Ann Surg Oncol. 2025 Apr 10. doi: 10.1245/s10434-025-17238-4.
9
Molecular Mechanism of WWOX Inhibiting the Development of Esophageal Cancer by Inhibiting Hippo Signaling Pathway.WWOX通过抑制Hippo信号通路抑制食管癌发展的分子机制
Biochem Genet. 2024 Jun 20. doi: 10.1007/s10528-024-10856-9.
10
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.Plk1 的过表达促进人食管鳞癌细胞的恶性进展。
J Cancer Res Clin Oncol. 2010 Jan;136(1):9-16. doi: 10.1007/s00432-009-0630-4.

引用本文的文献

1
Dual Targeting of Inflammatory and Immune Checkpoint Pathways to Overcome Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma.双重靶向炎症和免疫检查点通路以克服食管鳞状细胞癌的放疗抵抗
J Inflamm Res. 2025 Jul 12;18:9091-9106. doi: 10.2147/JIR.S531145. eCollection 2025.
2
ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma.ML385 通过抑制食管鳞癌细胞中的 NRF2-SLC7A11 通路促进铁死亡和放射敏感性。
Med Oncol. 2024 Nov 7;41(12):309. doi: 10.1007/s12032-024-02483-6.

本文引用的文献

1
Combined detection of peripheral blood VEGF and inflammation biomarkers to evaluate the clinical response and prognostic prediction of non-operative ESCC.联合检测外周血 VEGF 和炎症生物标志物评估非手术治疗 ESCC 的临床反应和预后预测。
Sci Rep. 2021 Jul 27;11(1):15305. doi: 10.1038/s41598-021-94329-8.
2
Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLC.连续低剂量阿帕替尼联合 WBRT 可显著减轻瘤周水肿并提高 NSCLC 症状性多发脑转移的疗效。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211011968. doi: 10.1177/15330338211011968.
3
Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years.
中国食管癌疾病负担的变化趋势:1990 年至 2017 年及未来 25 年的预测水平。
Cancer Med. 2021 Mar;10(5):1889-1899. doi: 10.1002/cam4.3775. Epub 2021 Feb 14.
4
Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors.食管和胃肿瘤的流行病学、诊断、分期及多模式治疗
Cancers (Basel). 2021 Feb 2;13(3):582. doi: 10.3390/cancers13030582.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries.食管癌的全球负担、风险因素及趋势:来自48个国家癌症登记处的分析
Cancers (Basel). 2021 Jan 5;13(1):141. doi: 10.3390/cancers13010141.
7
The Safety and Efficacy of Apatinib Treatment in Addition to Concurrent Chemoradiotherapy in Patients with Nonoperative Locally Advanced Esophageal Squamous Cell Carcinoma.阿帕替尼联合同步放化疗治疗不可手术切除的局部晚期食管鳞状细胞癌患者的安全性和有效性
Med Sci Monit. 2020 Nov 27;26:e927221. doi: 10.12659/MSM.927221.
8
Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF‑1α and VEGF expression.高氧通过下调 HIF-1α 和 VEGF 的表达使缺氧 HeLa 细胞对电离辐射敏感。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11700. Epub 2020 Nov 20.
9
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond.肝癌的联合免疫治疗:放射治疗、免疫检查点阻断及其他。
Front Immunol. 2020 Sep 30;11:568759. doi: 10.3389/fimmu.2020.568759. eCollection 2020.
10
VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway.VEGF knockdown 通过激活 mTOR 通路抑制自噬,增强鼻咽癌的放射敏感性。
Sci Rep. 2020 Oct 1;10(1):16328. doi: 10.1038/s41598-020-73310-x.